226 related articles for article (PubMed ID: 32681454)
1. Management Pearls on the Treatment of Actinic Keratoses and Field Cancerization.
Piquero-Casals J; Morgado-Carrasco D; Gilaberte Y; Del Rio R; Macaya-Pascual A; Granger C; López-Estebaranz JL
Dermatol Ther (Heidelb); 2020 Oct; 10(5):903-915. PubMed ID: 32681454
[TBL] [Abstract][Full Text] [Related]
2. Field Cancerization Therapies for Management of Actinic Keratosis: A Narrative Review.
Jetter N; Chandan N; Wang S; Tsoukas M
Am J Clin Dermatol; 2018 Aug; 19(4):543-557. PubMed ID: 29582369
[TBL] [Abstract][Full Text] [Related]
3. Interventions for actinic keratoses.
Gupta AK; Paquet M; Villanueva E; Brintnell W
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD004415. PubMed ID: 23235610
[TBL] [Abstract][Full Text] [Related]
4. The importance of treating the field in actinic keratosis.
Stockfleth E
J Eur Acad Dermatol Venereol; 2017 Mar; 31 Suppl 2():8-11. PubMed ID: 28263021
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of a photolyase-based device in the treatment of cancerization field in patients with actinic keratosis and non-melanoma skin cancer.
Puviani M; Barcella A; Milani M
G Ital Dermatol Venereol; 2013 Dec; 148(6):693-8. PubMed ID: 24442053
[TBL] [Abstract][Full Text] [Related]
6. Treatment considerations in actinic keratosis.
Goldenberg G
J Eur Acad Dermatol Venereol; 2017 Mar; 31 Suppl 2():12-16. PubMed ID: 28263018
[TBL] [Abstract][Full Text] [Related]
7. [Not Available].
Herms F
Ann Dermatol Venereol; 2019 May; 146 Suppl 2():IIS22-IIS30. PubMed ID: 31133226
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of different photoprotection strategies in preventing actinic keratosis new lesions after photodynamic therapy. The ATHENA study: a two-center, randomized, prospective, assessor-blinded pragmatic trial.
Pavone PS; Lovati S; Scarcella G; Milani M
Curr Med Res Opin; 2019 Jan; 35(1):141-145. PubMed ID: 30404544
[No Abstract] [Full Text] [Related]
9. European consensus-based interdisciplinary guideline for diagnosis, treatment and prevention of actinic keratoses, epithelial UV-induced dysplasia and field cancerization on behalf of European Association of Dermato-Oncology, European Dermatology Forum, European Academy of Dermatology and Venereology and Union of Medical Specialists (Union Européenne des Médecins Spécialistes).
Kandolf L; Peris K; Malvehy J; Mosterd K; Heppt MV; Fargnoli MC; Berking C; Arenberger P; Bylaite-Bučinskiene M; Del Marmol V; Dirschka T; Dreno B; Forsea AM; Harwood CA; Hauschild A; Heerfordt IM; Kauffman R; Kelleners-Smeets N; Lallas A; Lebbe C; Leiter U; Longo C; Mijušković Ž; Pellacani G; Puig S; Saiag P; Šitum M; Stockfleth E; Salavastru C; Stratigos A; Zalaudek I; Garbe C;
J Eur Acad Dermatol Venereol; 2024 Jun; 38(6):1024-1047. PubMed ID: 38451047
[TBL] [Abstract][Full Text] [Related]
10. Topical management of actinic keratosis and field cancerisation.
Stockfleth E
G Ital Dermatol Venereol; 2009 Aug; 144(4):459-62. PubMed ID: 19755950
[TBL] [Abstract][Full Text] [Related]
11. Review of Clinical Evidence over 10 Years on Prevention and Treatment of a Film-Forming Medical Device Containing Photolyase in the Management of Field Cancerization in Actinic Keratosis.
Puig S; Granger C; Garre A; Trullàs C; Sanmartin O; Argenziano G
Dermatol Ther (Heidelb); 2019 Jun; 9(2):259-270. PubMed ID: 30968311
[TBL] [Abstract][Full Text] [Related]
12. Evidence for field cancerisation treatment of actinic keratoses with topical diclofenac in hyaluronic acid.
Ulrich M; Pellacani G; Ferrandiz C; Lear JT
Eur J Dermatol; 2014; 24(2):158-67. PubMed ID: 24721544
[TBL] [Abstract][Full Text] [Related]
13. [Beyond actinic keratoses: Field cancerization of the skin].
Reygagne P; Rostain G
Ann Dermatol Venereol; 2018 Oct; 145(10):587-592. PubMed ID: 30243819
[TBL] [Abstract][Full Text] [Related]
14. How to treat actinic keratosis? An update.
Costa C; Scalvenzi M; Ayala F; Fabbrocini G; Monfrecola G
J Dermatol Case Rep; 2015 Jun; 9(2):29-35. PubMed ID: 26236409
[TBL] [Abstract][Full Text] [Related]
15. Actinic keratosis. Current treatment options.
Jeffes EW; Tang EH
Am J Clin Dermatol; 2000; 1(3):167-79. PubMed ID: 11702298
[TBL] [Abstract][Full Text] [Related]
16. Topical treatment of actinic keratoses in organ transplant recipients: a feasibility study for SPOT (Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments).
Hasan ZU; Ahmed I; Matin RN; Homer V; Lear JT; Ismail F; Whitmarsh T; Green AC; Thomson J; Milligan A; Hogan S; Van-de-Velde V; Mitchell-Worsford L; Kentley J; Gaunt C; Jefferson-Hulme Y; Bowden SJ; Gaunt P; Wheatley K; Proby CM; Harwood CA
Br J Dermatol; 2022 Sep; 187(3):324-337. PubMed ID: 34988975
[TBL] [Abstract][Full Text] [Related]
17. Updates on Treatment Approaches for Cutaneous Field Cancerization.
Huang A; Nguyen JK; Austin E; Mamalis A; Jagdeo J
Curr Dermatol Rep; 2019 Sep; 8(3):122-132. PubMed ID: 31475077
[TBL] [Abstract][Full Text] [Related]
18. Field cancerization: from molecular basis to selective field-directed management of actinic keratosis.
Philipp-Dormston WG
Curr Probl Dermatol; 2015; 46():115-21. PubMed ID: 25561215
[TBL] [Abstract][Full Text] [Related]
19. Pharmacoeconomic analysis of the treatment of multiple actinic keratoses.
Gold MH
J Drugs Dermatol; 2008 Jan; 7(1):23-5. PubMed ID: 18246694
[TBL] [Abstract][Full Text] [Related]
20. Management of actinic keratosis: a practical report and treatment algorithm from AKTeam™ expert clinicians.
Dréno B; Amici JM; Basset-Seguin N; Cribier B; Claudel JP; Richard MA;
J Eur Acad Dermatol Venereol; 2014 Sep; 28(9):1141-9. PubMed ID: 24612407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
